Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2017

19.05.2016 | Original Article

Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?

verfasst von: Xavier Giffroy, Nathalie Maes, Adelin Albert, Pierre Maquet, Jean-Michel Crielaard, Dominique Dive

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The clinical variability and complexity of multiple sclerosis (MS) challenges the individual clinical course prognostication. This study aimed to find out whether multimodal evoked potentials (EP) correlate with the motor components of multiple sclerosis functional composite (MSFCm) and predict clinically relevant motor functional deterioration. One hundred MS patients were assessed at baseline (T 0) and about 7.5 years later (T 1), with visual, somatosensory and motor EP and rated on the Expanded Disability Status Scale (EDSS) and the MSFCm, including the 9 Hole Peg Test and the Timed 25 Foot Walk (T25FW). The Spearman correlation coefficient (r S) was used to evaluate the cross-sectional and longitudinal relationship between EP Z scores and clinical findings. The predictive value of baseline electrophysiological data for clinical worsening (EDSS, 9-HPT, T25FW, MSFCm) during follow-up was assessed by logistic regression analysis. Unlike longitudinal correlations, cross-sectional correlations between EP Z scores and clinical outcomes were all significant and ranged between 0.22 and 0.67 (p < 0.05). The global EP Z score was systematically predictive of EDSS and MSFCm worsening over time (all p < 0.05). EP latency was a better predictor than amplitude, although weaker than latency and amplitude aggregation in the global EP Z score. The study demonstrates that EP numerical scores can be used for motor function monitoring and outcome prediction in patients with MS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Silber E, Sharief MK (1999) Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 170(1):11–18CrossRefPubMed Silber E, Sharief MK (1999) Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 170(1):11–18CrossRefPubMed
2.
Zurück zum Zitat Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354(1390):1649–1673CrossRefPubMedPubMedCentral Smith KJ, McDonald WI (1999) The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 354(1390):1649–1673CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Renoux C (2011) Natural history of multiple sclerosis: long-term prognostic factors. Neurol Clin 29(2):293–308CrossRefPubMed Renoux C (2011) Natural history of multiple sclerosis: long-term prognostic factors. Neurol Clin 29(2):293–308CrossRefPubMed
4.
Zurück zum Zitat Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K (2006) Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler 12(1):58–65CrossRefPubMed Kallmann BA, Fackelmann S, Toyka KV, Rieckmann P, Reiners K (2006) Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis. Mult Scler 12(1):58–65CrossRefPubMed
5.
Zurück zum Zitat Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD (2011) Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. J Neurol 258(11):1933–1939CrossRefPubMed Invernizzi P, Bertolasi L, Bianchi MR, Turatti M, Gajofatto A, Benedetti MD (2011) Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. J Neurol 258(11):1933–1939CrossRefPubMed
6.
Zurück zum Zitat Ramanathan S, Lenton K, Burke T, Gomes L, Storchenegger K, Yiannikas C, Vucic S (2013) The utility of multimodal evoked potentials in multiple sclerosis prognostication. J Clin Neurosci 20(11):1576–1581CrossRefPubMed Ramanathan S, Lenton K, Burke T, Gomes L, Storchenegger K, Yiannikas C, Vucic S (2013) The utility of multimodal evoked potentials in multiple sclerosis prognostication. J Clin Neurosci 20(11):1576–1581CrossRefPubMed
7.
Zurück zum Zitat Schlaeger R, Schindler C, Grize L, Dellas S, Radue EW, Kappos L, Fuhr P (2014) Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years. Mult Scler 20(10):1348–1354CrossRefPubMed Schlaeger R, Schindler C, Grize L, Dellas S, Radue EW, Kappos L, Fuhr P (2014) Combined visual and motor evoked potentials predict multiple sclerosis disability after 20 years. Mult Scler 20(10):1348–1354CrossRefPubMed
8.
Zurück zum Zitat Schlaeger R, D’Souza M, Schindler C, Grize L, Kappos L, Fuhr P (2014) Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis. Mult Scler 20(1):51–56CrossRefPubMed Schlaeger R, D’Souza M, Schindler C, Grize L, Kappos L, Fuhr P (2014) Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis. Mult Scler 20(1):51–56CrossRefPubMed
9.
Zurück zum Zitat Margaritella N, Mendozzi L, Garegnani M, Colicino E, Gilardi E, Deleonardis L, Tronci F, Pugnetti L (2012) Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis. Neurol Sci 33(4):887–892CrossRefPubMed Margaritella N, Mendozzi L, Garegnani M, Colicino E, Gilardi E, Deleonardis L, Tronci F, Pugnetti L (2012) Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis. Neurol Sci 33(4):887–892CrossRefPubMed
10.
Zurück zum Zitat Sharrack B, Hughes RA (1996) Clinical scales for multiple sclerosis. J Neurol Sci 135(1):1–9CrossRefPubMed Sharrack B, Hughes RA (1996) Clinical scales for multiple sclerosis. J Neurol Sci 135(1):1–9CrossRefPubMed
11.
Zurück zum Zitat Jung P, Beyerle A, Ziemann U (2008) Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis. Mult Scler 14(4):553–556CrossRefPubMed Jung P, Beyerle A, Ziemann U (2008) Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis. Mult Scler 14(4):553–556CrossRefPubMed
12.
Zurück zum Zitat Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122(Pt 5):871–882CrossRefPubMed Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122(Pt 5):871–882CrossRefPubMed
13.
Zurück zum Zitat Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS (2000) Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol 57(9):1319–1324PubMed Miller DM, Rudick RA, Cutter G, Baier M, Fischer JS (2000) Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. Arch Neurol 57(9):1319–1324PubMed
14.
Zurück zum Zitat Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM, Polman CH (2006) Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 12(5):594–598CrossRefPubMed Kragt JJ, van der Linden FA, Nielsen JM, Uitdehaag BM, Polman CH (2006) Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis. Mult Scler 12(5):594–598CrossRefPubMed
15.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRefPubMed McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRefPubMed
16.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452CrossRefPubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452CrossRefPubMed
17.
Zurück zum Zitat Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 5:244–250CrossRefPubMed Fischer JS, Rudick RA, Cutter GR, Reingold SC (1999) The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 5:244–250CrossRefPubMed
18.
Zurück zum Zitat Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124(Pt 11):2162–2168CrossRefPubMed Fuhr P, Borggrefe-Chappuis A, Schindler C, Kappos L (2001) Visual and motor evoked potentials in the course of multiple sclerosis. Brain 124(Pt 11):2162–2168CrossRefPubMed
19.
Zurück zum Zitat Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G (2006) Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77(9):1030–1035CrossRefPubMedPubMedCentral Leocani L, Rovaris M, Boneschi FM, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G (2006) Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study. J Neurol Neurosurg Psychiatry 77(9):1030–1035CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kaufman M, Moyer D, Norton J (2000) The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 6(4):286–290CrossRefPubMed Kaufman M, Moyer D, Norton J (2000) The significant change for the Timed 25-foot Walk in the multiple sclerosis functional composite. Mult Scler 6(4):286–290CrossRefPubMed
21.
Zurück zum Zitat Schlaeger R, D’Souza M, Schindler C, Grize L, Kappos L, Fuhr P (2012) Combined evoked potentials as markers and predictors of disability in early multiple sclerosis. Clin Neurophysiol 123(2):406–410CrossRefPubMed Schlaeger R, D’Souza M, Schindler C, Grize L, Kappos L, Fuhr P (2012) Combined evoked potentials as markers and predictors of disability in early multiple sclerosis. Clin Neurophysiol 123(2):406–410CrossRefPubMed
22.
Zurück zum Zitat Canham LJ, Kane N, Oware A, Walsh P, Blake K, Inglis K, Homewood J, Witherick J, Faulkner H, White P, Lewis A, Furse-Roberts C, Cottrell DA (2015) Multimodal neurophysiological evaluation of primary progressive multiple sclerosis—an increasingly valid biomarker, with limits. Mult Scler Relat Disord 4(6):607–613CrossRefPubMed Canham LJ, Kane N, Oware A, Walsh P, Blake K, Inglis K, Homewood J, Witherick J, Faulkner H, White P, Lewis A, Furse-Roberts C, Cottrell DA (2015) Multimodal neurophysiological evaluation of primary progressive multiple sclerosis—an increasingly valid biomarker, with limits. Mult Scler Relat Disord 4(6):607–613CrossRefPubMed
23.
Zurück zum Zitat Rico A, Audoin B, Franques J, Eusebio A, Reuter F, Malikova I, Ali Cherif A, Pouget J, Pelletier J, Attarian S (2009) Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 15(3):355–362CrossRefPubMed Rico A, Audoin B, Franques J, Eusebio A, Reuter F, Malikova I, Ali Cherif A, Pouget J, Pelletier J, Attarian S (2009) Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 15(3):355–362CrossRefPubMed
24.
Zurück zum Zitat Buhler R, Magistris MR, Truffert A, Hess CW, Rosler KM (2001) The triple stimulation technique to study central motor conduction to the lower limbs. Clin Neurophysiol 112(5):938–949CrossRefPubMed Buhler R, Magistris MR, Truffert A, Hess CW, Rosler KM (2001) The triple stimulation technique to study central motor conduction to the lower limbs. Clin Neurophysiol 112(5):938–949CrossRefPubMed
25.
Zurück zum Zitat Feuillet L, Pelletier J, Suchet L, Rico A, Ali Cherif A, Pouget J, Attarian S (2007) Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a: a pilot study. Mult Scler 13(3):348–356CrossRefPubMed Feuillet L, Pelletier J, Suchet L, Rico A, Ali Cherif A, Pouget J, Attarian S (2007) Prospective clinical and electrophysiological follow-up on a multiple sclerosis population treated with interferon beta-1 a: a pilot study. Mult Scler 13(3):348–356CrossRefPubMed
26.
Zurück zum Zitat Pallix-Guyot M, Guennoc AM, Blasco H, de Toffol B, Corcia P, Praline J (2011) Predictive value of motor evoked potentials in clinically isolated syndrome. Acta Neurol Scand 124(6):410–416CrossRefPubMed Pallix-Guyot M, Guennoc AM, Blasco H, de Toffol B, Corcia P, Praline J (2011) Predictive value of motor evoked potentials in clinically isolated syndrome. Acta Neurol Scand 124(6):410–416CrossRefPubMed
27.
Zurück zum Zitat Pelayo R, Montalban X, Minoves T, Moncho D, Rio J, Nos C, Tur C, Castillo J, Horga A, Comabella M, Perkal H, Rovira A, Tintore M (2010) Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler 16(1):55–61CrossRefPubMed Pelayo R, Montalban X, Minoves T, Moncho D, Rio J, Nos C, Tur C, Castillo J, Horga A, Comabella M, Perkal H, Rovira A, Tintore M (2010) Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler 16(1):55–61CrossRefPubMed
28.
Zurück zum Zitat Grasso MG, Pace L, Troisi E, Tonini A, Paolucci S (2009) Prognostic factors in multiple sclerosis rehabilitation. Eur J Phys Rehabil Med 45(1):47–51PubMed Grasso MG, Pace L, Troisi E, Tonini A, Paolucci S (2009) Prognostic factors in multiple sclerosis rehabilitation. Eur J Phys Rehabil Med 45(1):47–51PubMed
29.
Zurück zum Zitat Comi G, Leocani L, Medaglini S, Locatelli T, Martinelli V, Santuccio G, Rossi P (1999) Measuring evoked responses in multiple sclerosis. Mult Scler 5(4):263–267CrossRefPubMed Comi G, Leocani L, Medaglini S, Locatelli T, Martinelli V, Santuccio G, Rossi P (1999) Measuring evoked responses in multiple sclerosis. Mult Scler 5(4):263–267CrossRefPubMed
30.
Zurück zum Zitat Magistris MR, Rosler KM, Truffert A, Landis T, Hess CW (1999) A clinical study of motor evoked potentials using a triple stimulation technique. Brain 122(Pt 2):265–279CrossRefPubMed Magistris MR, Rosler KM, Truffert A, Landis T, Hess CW (1999) A clinical study of motor evoked potentials using a triple stimulation technique. Brain 122(Pt 2):265–279CrossRefPubMed
31.
Zurück zum Zitat Criste G, Trapp B, Dutta R (2014) Axonal loss in multiple sclerosis: causes and mechanisms. Handb Clin Neurol 122:101–113CrossRefPubMed Criste G, Trapp B, Dutta R (2014) Axonal loss in multiple sclerosis: causes and mechanisms. Handb Clin Neurol 122:101–113CrossRefPubMed
Metadaten
Titel
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
verfasst von
Xavier Giffroy
Nathalie Maes
Adelin Albert
Pierre Maquet
Jean-Michel Crielaard
Dominique Dive
Publikationsdatum
19.05.2016
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2017
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-016-0650-1

Weitere Artikel der Ausgabe 1/2017

Acta Neurologica Belgica 1/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.